Halifax-based consumer health products company recognized as a world technology leader
January 22, Halifax – Origin BioMed Inc., a privately-held
Canadian consumer health products company, today announced that it has
been awarded as one of the Red Herring Top 100 Global Companies.
Red Herring Top 100 Global Companies are chosen from winners and
finalists of the previous competitions for North America, Europe and
Asia Red Herring Top 100 Companies. Out of 1,800 successful and highly
eligible companies, the Red Herring editorial team deployed a detailed
process to drill-down the best companies first to 200 finalists, then
to the top 100 winners of this global award. Evaluations were made on
both quantitative and qualitative criteria, such as financial
performance, innovation, management, global strategy, and ecosystem
integration.
The announcement of the winners was made at the Red Herring 100 Global
taking place in San Diego from January 14-16, 2009. Present among the
finalists were elite executives and venture capital leaders from around
the world.
“We were so pleased to announce Origin BioMed Inc. as a Red Herring
Top 100 Global Company,” commented Red Herring publisher Alex Vieux.
“Origin BioMed has proven to be a company excelling in their industry
and its ripples have turned into waves. It was difficult for us to
narrow down, but we are pleased to have included Origin BioMed in our
list of promising companies. We look forward to the changes it makes
to the non-prescription drug industry in the future.” Origin was one
of only 4 Canadian companies to receive the Award, with companies from
25 other countries also receiving the award.
Origin BioMed’s leading drug product, Neuragen®, is the first
non-prescription topical treatment for rapid relief of diabetic and
post-shingles nerve pain. Neuragen is available in all leading
pharmacies in Canada and the United States.
|